Bath & Body Works (NYSE:BBWI) Issues FY 2026 Earnings Guidance

Bath & Body Works (NYSE:BBWIGet Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 2.400-2.650 for the period, compared to the consensus EPS estimate of 2.560. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Bath & Body Works also updated its Q2 2026 guidance to 0.300-0.300 EPS.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Barclays upped their price target on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, March 2nd. Deutsche Bank Aktiengesellschaft upped their price target on Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Tuesday, March 3rd. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday. Telsey Advisory Group upped their price target on Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a research report on Thursday, March 5th. Finally, Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and upped their price target for the company from $21.00 to $25.00 in a research report on Tuesday, February 17th. Three equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of “Hold” and a consensus price target of $21.21.

View Our Latest Analysis on Bath & Body Works

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $19.56 on Thursday. Bath & Body Works has a 1-year low of $14.27 and a 1-year high of $33.96. The business’s fifty day moving average price is $18.65 and its two-hundred day moving average price is $20.24. The firm has a market capitalization of $3.94 billion, a PE ratio of 6.21, a P/E/G ratio of 1.76 and a beta of 1.43.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period last year, the company earned $0.49 earnings per share. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts expect that Bath & Body Works will post 2.61 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, June 5th. This represents a $0.80 annualized dividend and a yield of 4.1%. Bath & Body Works’s dividend payout ratio (DPR) is currently 25.40%.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC acquired a new stake in Bath & Body Works in the fourth quarter worth $31,000. Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the period. Parallel Advisors LLC increased its position in Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after buying an additional 567 shares during the period. Danske Bank A S bought a new position in shares of Bath & Body Works in the third quarter worth $39,000. Finally, Advisory Services Network LLC bought a new position in shares of Bath & Body Works in the third quarter worth $48,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Further Reading

Earnings History and Estimates for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.